Rob Shaffer
Company: Vrata Therapeutics
Job title: Co-Founder & Chief Operating Officer
Seminars:
Emerging Strategies to Deliver RNA-Targeted Therapeutics to Extra-Hepatic Tissues 9:30 am
day: Pre-Conference Focus Day
Roundtable Discussion: Evaluating the Promise of Conjugates to Address Key Delivery Bottlenecks such as Enabling Re-Dosing & Increasing Endosomal Escape 10:00 am
What are some advantages and disadvantages of using conjugated delivery platforms over other methods such as viral delivery and lipid nanoparticles? How can ligands be utilized and optimized to increase the chance of endosomal escape to improve payload delivery? What would an ideal conjugated delivery platform look like, from PK to CMC? What hurdles do…Read more
day: Pre-Conference Focus Day